Cysteine requirements for preterm infants

Completed

• Conditions: Premature infants, glutathione (GSH) deficiency; Neonatal Diseases; Nutritional deficiency

• Registration Number: ISRCTN35832828
• Lead Sponsor: Sophia Foundation For Scientific Research (SSWO) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Infants born with a gestational age of 26 - 29 weeks will be studied at a post-conceptional age of 30 - 32 weeks and at a post-conceptional age of 35 - 37 weeks
2. Infants born at a gestational age of 32 - 34 weeks will also be studied at a post-conceptional age of 35 - 37 weeks

Exclusion Criteria

1. Congenital metabolic disease
2. Congenital anomalies
3. Gastrointestinal diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Fractional oxidation of 13C-phenylalanine<br>2. Whole body flux of 13C-phenylalanine

Secondary Outcome Measures

Name	Time	Method
o secondary outcome measures